Results
|
18401.
|
|
|
18402.
|
Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer. [electronic resource] by
- Morris, Michael J
- Tong, William P
- Cordon-Cardo, Carlos
- Drobnjak, Marija
- Kelly, William K
- Slovin, Susan F
- Terry, Kathryn L
- Siedlecki, Karen
- Swanson, Paul
- Rafi, Mohmed
- DiPaola, Robert S
- Rosen, Neal
- Scher, Howard I
Producer: 20020703
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 8
Availability: No items available.
|
|
18403.
|
|
|
18404.
|
|
|
18405.
|
|
|
18406.
|
|
|
18407.
|
|
|
18408.
|
|
|
18409.
|
|
|
18410.
|
|
|
18411.
|
|
|
18412.
|
|
|
18413.
|
|
|
18414.
|
|
|
18415.
|
|
|
18416.
|
|
|
18417.
|
|
|
18418.
|
|
|
18419.
|
|
|
18420.
|
|